Neuraxpharm has struck a deal to acquire Irish distribution firm Medinutrix in a transaction that will give the central nervous system specialist “both the platform and the local expertise to launch new products in the Irish market for the first time.” Terms of the agreement were not disclosed.
In particular, Neuraxpharm said the transaction would “provide an immediate platform for the recently acquired market-leading epilepsy treatment Buccolam (midazolam)...
